Effect of variable antidiabetic treatments strategy on oxidative stress markers in obese patients with T2DM

Abeer A. ALrefai; Alsayed M. Alsalamony; Sameer H. Fatani; Hala F. M. Kamel

Effect of variable antidiabetic treatments strategy on oxidative stress markers in obese patients with T2DM

2017

Abeer A. ALrefai | Alsayed M. Alsalamony | Sameer H. Fatani | Hala F. M. Kamel

Abstract Aim To evaluate the effect of different anti-diabetic treatment strategy on oxidative stress markers in patients with type 2 diabetes mellitus (T2DM). Subject and methods A total of 93 patients with T2DM treated with metformin (G1 = 25), OHA (G2 = 22), OA and insulin (G3 = 26) and insulin alone (G4 = 20). In all patients, lipid profile and glycemic indices were assessed using routine laboratory tests. MDA and Oxidized LDL were assessed using commercially available ELISA kits. Laboratory tests were performed at baseline and at a control visit after 24 weeks of treatment. Results A significant decrease in the levels of MDA with improvement of glycemic control was observed in the group receiving OHA in combination with insulin therapy. A similar decrease of oxLDL was observed in all diabetic subgroups with borderline significance in those receiving metformin alone. The remaining clinical and biochemical parameters were not changed during follow-up in any of the involved groups. Conclusion A combination therapy with insulin was more effective in glycemic control and MDA reduction in T2DM. Whereas, a significant oxLDLc reduction was observed in T2DM irrespective of categories of antidiabetic treatment or glycemic control.

اظهر المزيد [+]